Prosecution Insights
Last updated: May 29, 2026

Examiner: SWIFT, CANDICE LEE

Tech Center 1600 • Art Units: 1653 1657

This examiner grants 58% of resolved cases

Performance Statistics

58.3%
Allow Rate
-1.7% vs TC avg
172
Total Applications
+38.5%
Interview Lift
1139
Avg Prosecution Days
Based on 115 resolved cases, 2023–2026

Rejection Statute Breakdown

4.5%
§101 Eligibility
6.0%
§102 Novelty
37.6%
§103 Obviousness
15.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18274757 ENGINEERED BACTERIA AND METHODS OF PRODUCING TRIACYLGLYCERIDES Non-Final OA PRESIDENT AND FELLOWS OF HARVARD COLLEGE
17917427 Keratin-Based Substrate and Methods of Forming the Same Final Rejection President and Fellows of Harvard College
18685498 NOVEL ACETOHYDROXY ACID SYNTHASE SUBUNIT VARIANT AND METHOD FOR PRODUCING L-VALINE USING SAME Non-Final OA CJ CHEILJEDANG CORPORATION
18488913 MICROBIAL CONSORTIUM AND USES THEREOF Non-Final OA The Regents of the University of California
18561144 NOVEL TECHNOLOGY TO ENABLE SUCROSE UTILIZATION IN STRAINS FOR BIOSYNTHETIC PRODUCTION Non-Final OA DSM IP Assets B.V.
17414839 PHAGE RESISTANT LACTIC ACID BACTERIA Non-Final OA DSM IP ASSETS B.V.
18570566 POLYHYDROXYALKANOATES AND METHODS OF MAKING THEREOF Non-Final OA The Board of Trustees of the Leland Stanford Junior University
18255203 ENGINEERED PROBIOTIC COMPOSITIONS AND USES THEREOF Non-Final OA MASSACHUSETTS INSTITUTE OF TECHNOLOGY
18686227 METHOD FOR PRODUCING PROTEIN MATERIAL WITHOUT USING ORGANIC SOLVENT Non-Final OA TOPPAN HOLDINGS INC.
18393145 Preparation Method and Enrichment Method for Cyanidin-3-Diglucoside-5-Glucoside Final Rejection China Agricultural University
18165051 METHODS AND COMPOSITIONS FOR THE DETECTION OF BETA-LACTAMASES Final Rejection Becton, Dickinson and Company
18670411 METHOD FOR TREATMENT AND CONTROL OF PLANT DISEASE Final Rejection The Texas A&M University System
18547256 AN ARTIFICIAL TRAP-CAGE, ITS USE AND METHOD OF PREPARING THEREOF Non-Final OA UNIWERSYTET JAGIELLONSKI
17799051 RECOMBINANT SILK SOLIDS AND FILMS Final Rejection BOLT THREADS, INC.
17279259 METHODS OF TREATING AND DIAGNOSING INFLAMMATORY BOWEL DISEASE Non-Final OA CEDARS-SINAI MEDICAL CENTER
18649596 MUTANTS OF BACILLUS AND METHODS FOR THEIR USE Non-Final OA Bayer CropScience LP
18329652 METHOD FOR DETECTING AMMONIA NITROGEN CONTENT BY USING NITRIFICATION BIOLOGICAL REACTION Final Rejection WUYI UNIVERSITY
18444307 PROCESS FOR FRACTIONATION OF PHOTOSYNTHETIC BIOMASS AND RELATED SYSTEMS AND METHODS Non-Final OA Filament Biosciences, LLC.
17273144 METHOD OF PRODUCING DOCOSAHEXAENOIC ACID CONTAINING GLYCERIDE USING A LIPASE HYDROLYSIS REACTION Final Rejection Nissui Corporation
18278169 METHODS OF AND COMPOSITIONS FOR TREATMENT OF UPPER LIMB SPASTICITY Final Rejection REVANCE THERAPEUTICS, INC.
18574497 METHOD FOR PURIFYING CLOSTRIDIUM BOTULINUM TOXIN COMPLEX PROTEIN Non-Final OA PHARMA RESEARCH BIO CO., LTD.
17610224 Methods for production of strictosidine aglycone and monoterpenoid indole alkaloids Non-Final OA DANMARKS TEKNISKE UNIVERSITET
18573298 COMPOSITIONS OF BETA-HEXOSAMINIDASE VARIANTS AND USES THEREOF Non-Final OA BIOMARIN PHARMACEUTICAL INC.
18527538 SUPPLEMENT COMPOSITION FOR CONSUMPTION BY INDIVIDUALS BEING ADMINISTERED A GLP-1 AGONIST Non-Final OA Food Sciences Corp.
18037204 TREATMENT OR PREVENTION OF HIV INFECTION Final Rejection Janssen Sciences Ireland Unlimited Company
18000634 ENHANCED hAT FAMILY MEMBER SPIN TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS Non-Final OA R&D SYSTEMS, INC.
18548719 Method of Evaluating the Biofilm Detachment Efficacy of Compositions Non-Final OA The Ohio State University
16469788 METHOD FOR PRODUCING PSICOSE BY USING PSICOSE EPIMERASE PRODUCING MICROORGANISM Final Rejection SAMYANG CORPORATION
18264307 BOTULINUM TOXIN FREEZE-DRIED FORMULATION DOSAGE FORM STORABLE FOR LONG TIME Non-Final OA DAEWOONG CO., LTD.
18001637 DETERGENT AND METHOD FOR PURIFYING A BIOTHERAPEUTIC Final Rejection MEDIMMUNE, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month